NEOGENOMICS INC — Director's Dealing 2012

Dec 20, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2012-12-18

Reporting Person: JONES STEVEN C (Director, Executive VP of Finance, 10% Owner)
Reporting Person: ASPEN SELECT HEALTHCARE LP (Director, Executive VP of Finance, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-18	Common Stock	S	632114	$2.75	Disposed	7376009	Indirect
2012-12-19	Common Stock	S	8225	$2.75	Disposed	7367784	Indirect
2012-12-20	Common Stock	S	1100	$2.75	Disposed	7366684	Indirect
2012-12-20	Common Stock	J	3653715	$2.75	Disposed	3712969	Indirect
2012-12-20	Common Stock	G	22640	$2.75	Disposed	346615	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	50476	Indirect
Common Stock	34857	Indirect
Common Stock	190000	Indirect
Common Stock	129412	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants (Right to Buy)	$1.5	2017-05-03	Common Stock (0)	450000	Direct
Warrants (Right to Buy)	$0.75	2014-02-09	Common Stock (0)	83333	Indirect

Footnotes

F1: Aspen Select Healthcare, LP is a private investment fund. Medical Venture Partners, LLC is the sole general partner of Aspen Select Healthcare, LP, and Mr. Jones is a Managing Member of Medical Venture Partners, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F2: An investment partnership entity controlled by Steven Jones. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F3: Such warrants were issued in connection with a consulting agreement, dated 5/3/2010.

F4: This was a distribution of shares to certain limited partners of Aspen Select Healthcare, LP in conjunction with the final distribution of their limited partnership interests.